CB-213

N/A

Report date: 2024/07/04 18:03:02

Base Information

Drug NameCB-213
Drug Alias NameCB-213
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionProgrammed cell death protein 1 antagonistsLymphocyte activation gene 3 protein antagonists
TargetsProgrammed cell death protein 1Lymphocyte activation gene 3 protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrescendo Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrescendo Bioscience IncCancer Research UK
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A